<DOC>
	<DOCNO>NCT00971256</DOCNO>
	<brief_summary>Review bladder cancer patient form database regard urine cytology .</brief_summary>
	<brief_title>Urine Cytology Utility Bladder Recurrence</brief_title>
	<detailed_description>In 2008 estimate 68,810 new case bladder cancer , 14,100 death . On list morbidity due cancer , bladder cancer rank number nine , yet number one dollar spent per cancer diagnosis treatment . Guidelines include cystoscopy cytology/urine study every three month first 2 year every 6 month next 2 year , cycle reset every recurrence . Urine cytology currently consider gold standard urine test many pro con . The point keep use include : high specificity , ability detect upper tract occurrence , ability monitor small population bladder cancer whose disease become aggressive . Opponents cytology refer fact low sensitivity fairly subjective new marker comparison improve . There multiple journal article document performance cytology new marker , new marker versus cytology performance cytology tandem new marker . The bottom line often overlook cytology expensive new marker least expensive cytology . With fact person diagnose non invasive bladder cancer 13 urine cytology 's 5 year without recurrence believe new rational recommendation need make regard urine study bladder cancer follow .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Bladder cancer patient Dr. Jay Hollander 's private practice . Patients diagnosis bladder cancer without initial cytology available . Patients receive outside nephrectomy cystectomy without pathology available . Those recurrence without cytology result available . Those follow Dr Hollander another urologist record miss significant number follow ups .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Bladder</keyword>
	<keyword>Cancer</keyword>
	<keyword>Cytology</keyword>
</DOC>